HIVandHepatitis.com
HIV and AIDS Topics
Top News Articles
 
FDA-approved Treatments 
Experimental Treatments
Women / Children
Metabolic Complications
Opportunistic Infections
 Google Custom Search
Zerit (d4T, stavudine)

Articles on Zerit
Full US Prescribing Information

Zerit is in a category of HIV medications called nucleoside reverse transcriptase inhibitors (NRTIs).

Zerit, manufactured by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration for the treatment of HIV in 1994.


Articles on Zerit


Benefits versus Risks of Stavudine (Zerit) Therapy for HIV-related Neurological Complications - 2/03/09

Longer Exposure to NRTIs, especially Stavudine (Zerit), Increases the Risk of Insulin Resistance in Women with HIV - 1/30/09


What Is the Impact on Lipoatrophy and Dyslipidemia of Reducing the Dose of d4T (Zerit) Compared with Switching to Tenofovir (Viread)?
- 1/15/08


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sign Up To Receive Our
Twice Weekly e-NEWSLETTER
Library of CME Programs
Protease Inhibitors
Agenerase (amprenavir)
Aptivus
(tipranavir)
Crixivan
(indinavir)
Invirase
(saquinavir hard gel)
Kaletra
(lopinavir/ritonavir)
Lexiva
(fosamprenavir)
Norvir
(ritonavir)
Prezista
(darunavir)
Reyataz
(atazanavir)
Viracept
(nelfinavir)
Nucleoside / Nucleotide Reverse
Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry
(maraviroc)
Fixed Dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)